Neuromuscular Disorders: In Vitro

This feed focuses on experimental systems, including cell and tissue-based therapies, as well as genomic and proteomic approaches, used to study neuromuscular disorders in vitro.

July 10, 2020
Open Access

Optimized method for extraction of exosomes from human primary muscle cells

Skeletal Muscle
Laura Le GallStephanie Duguez
June 28, 2020

Accelerated outgrowth in cross-facial nerve grafts wrapped with adipose-derived stem cell sheets

Journal of Tissue Engineering and Regenerative Medicine
Kaori FujiiHiroyuki Sakurai
July 15, 2020
Review

Inclusion body myositis in the rheumatology clinic

International Journal of Rheumatic Diseases
Anu BalakrishnanLatika Gupta
July 1, 2020

"Mozart effect" for Parkinson's disease: music as medicine

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Daniella Balduino VictorinoFulvio A Scorza
July 21, 2020
Open Access

Praja1 RING-finger E3 ubiquitin ligase suppresses neuronal cytoplasmic TDP-43 aggregate formation

Neuropathology : Official Journal of the Japanese Society of Neuropathology
Kazuhiko WatabeNoriyuki Shibata
July 7, 2020

Double Trouble from POLG1 and CLCN1 Variants with Intrafamilial Phenotypic Heterogeneity

Movement Disorders Clinical Practice
Josef Finsterer
July 16, 2020

Splicing impact of deep exonic missense variants in CAPN3 explored systematically by minigene functional assay

Human Mutation
Eugénie DionnetSvetlana Gorokhova
July 30, 2020
Preprint

Three-Component Model of the Spinal Nerve Branching Pattern, based on the View of the Lateral Somitic Frontier and Experimental Validation

BioRxiv : the Preprint Server for Biology
Shunsaku HommaH. Yaginuma
July 7, 2020
Review

ALS, a cellular whodunit on motor neuron degeneration

Molecular and Cellular Neurosciences
Peter Karagiannis, Haruhisa Inoue
July 3, 2020

Multisystem disease including stroke, epilepsy, dystonia, noncompaction, and kidney agenesis requires genetic work-up

Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery
Josef Finsterer
July 9, 2020
Open Access

Simple Method to Quantify Protein Abundances from 1000 Cells

ACS Omega
Burcu VitrinelChristine Vogel
July 4, 2020
Preprint
Open Access

Hyperkalemia, not apoptosis, accurately predicts insect chilling injury

BioRxiv : the Preprint Server for Biology
J. CarringtonHeath A MacMillan
July 21, 2020

Is the variant m.9176T>C in MT-ATP6 truly responsibly for Leigh syndrome?

Pediatrics International : Official Journal of the Japan Pediatric Society
Josef Finsterer
July 21, 2020
Review

MEGDEL Syndrome

Pediatric Neurology
Josef FinstererCarla A Scorza

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Antisense Oligonucleotide - Therapies For ALS

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

© 2020 Meta ULC. All rights reserved
/feed-previews/neuromuscular-disorders-in-vitro/60d14e6a-e0fd-4e9c-8c49-3abfd322698c